SCHEMBL12989289

SCHEMBL12989289

N=C(N)c1ccc(OCC#CC#CCOc2ccc(C(=N)N)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRSS1 P07477 9/20 0.63
▸ TMPRSS2 O15393 2/20 0.61
▸ PRMT1 Q99873 3/20 0.59
▸ F2 P00734 3/20 0.59
▸ ST14 Q9Y5Y6 3/20 0.59
▸ PRSS2 P07478 2/20 0.59
▸ PRSS3 P35030 2/20 0.59
▸ PLAU P00749 1/20 0.59
▸ PRMT5 O14744 1/20 0.59
▸ SLC22A2 O15244 1/20 0.59
▸ SLC22A1 O15245 1/20 0.59
▸ PTP4A3 O75365 1/20 0.59
▸ SLC22A3 O75751 1/20 0.59
▸ F10 P00742 1/20 0.59
▸ PLG P00747 1/20 0.59
▸ S100B P04271 1/20 0.59
▸ CHRM2 P08172 1/20 0.59
▸ CHRM4 P08173 1/20 0.59
▸ CHRM5 P08912 1/20 0.59
▸ ADRA2A P08913 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8438444 0.81 PRSS1 (0.63) PRSS1TMPRSS2PRMT1F2ST14
SCHEMBL12348319 0.78 PRSS1 (0.76) PRSS1TMPRSS2PRMT1F2ST14
Hydrochloric Acid SCHEMBL11784186 0.76 PRSS1 (0.77) PRSS1TMPRSS2PRMT1F2ST14
SCHEMBL6408670 0.76 PRSS1 (1.00) PRSS1TMPRSS2PRMT1F2ST14
Propamidine SCHEMBL231060 0.76 TMPRSS2 (1.00) PRSS1TMPRSS2PRMT1F2ST14
Hydrochloric Acid SCHEMBL11783188 0.76 PRSS1 (1.00) PRSS1TMPRSS2PRMT1F2ST14
SCHEMBL19489122 0.75 PRSS1 (0.70) PRSS1TMPRSS2PRMT1F2ST14
SCHEMBL1715535 0.75 PRSS1 (0.70) PRSS1TMPRSS2PRMT1F2ST14
SCHEMBL428950 0.75 PRSS1 (1.00) PRSS1TMPRSS2PRMT1F2ST14
Propamidine SCHEMBL2689252 0.75 PRSS1 (1.00) PRSS1TMPRSS2PRMT1F2ST14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8436049-B2 Uses of pentamidine and related compounds STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) 2013-05-07 — — US disclosed
US-8436049-B2 Uses of pentamidine and related compounds STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) 2013-05-07 — — US disclosed
US-20100323993-A1 USES OF PENTAMIDINE AND RELATED COMPOUNDS STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON 2010-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100323993-A1 USES OF PENTAMIDINE AND RELATED COMPOUNDS MBNL1, MTPN, RRBP1 PRSS1 2567/4885TMPRSS2 3609/4885PRMT1 749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback